An Open-label, Multi-center, Long-term Extension Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

Aún no reclutaFase 3ClinicalTrials.gov

ID: NCT07441408Tipo: INTERVENTIONALInicio: 16 de dic de 2026Fin estimado: 30 de mar de 2030

Traducción no disponible, mostrando original

Resumen

The purpose of this study is to evaluate the long-term safety and tolerability of Admilparant in participants who completed participation in parent studies IM027-068 (for idiopathic pulmonary fibrosis (IPF)) and IM027-1015 (for progressive pulmonary fibrosis (PPF)).

Elegibilidad

Sexo: ALL

Criterios de inclusión

\- Participants must have completed participation in either IM027068 or IM0271015 (defined as receiving study intervention (IMP) until completion of EOT visit).

Criterios de exclusión

Clinically significant AE that resulted in discontinuation or interruption of IMP (Investigational Medicinal Product) in IM027068 or IM0271015 without reinitiation of IMP.
Exhibit symptoms of heart failure at rest.
History of lung reduction surgery or lung transplant. Note: Being on the transplantation list is allowed.
Participants with known PAH (Pulmonary Arterial Hypertension) who has been on single drug therapy that now requires multi-drug therapy.

Intervenciones

drug

BMS-986278

Specified dose on specified days

Ubicaciones

Local Institution - 0013

Florida, Vicente López, Buenos Aires, Argentina

Site 0013

Local Institution - 0014

Mar del Plata, Buenos Aires, Argentina

Site 0014

Local Institution - 0007

Quilmes, Buenos Aires, Argentina

Site 0007

Local Institution - 0009

San Juan Bautista, Buenos Aires, Argentina

Site 0009

Local Institution - 0003

Mar del Plata, B, Argentina

Site 0003

Local Institution - 0001

Córdoba, Córdoba Province, Argentina

Site 0001

Local Institution - 0002

Godoy Cruz, Mendoza Province, Argentina

Site 0002

Local Institution - 0011

Mendoza, M, Argentina

Site 0011

Local Institution - 0015

Rosario, S, Argentina

Site 0015

Local Institution - 0010

Buenos Aires, Argentina

Site 0010

Local Institution - 0008

Santa Fe, Argentina

Site 0008

Patrocinadores

PrincipalBristol-Myers Squibb

Contactos

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

CONTACT

Clinical.Trials@bms.com 855-907-3286

First line of the email MUST contain NCT # and Site #.

CONTACT

Aviso: La información de este ensayo proviene de fuentes públicas y tiene carácter exclusivamente informativo. No constituye asesoramiento médico, regulatorio ni de ningún otro tipo. Las traducciones son automatizadas y no poseen validez oficial. Consultá siempre con un profesional de la salud. Ver Términos de Uso.

An Open-label, Multi-center, Long-term Extension Study to... | EligiMed